Key Funding

2012-2017 BHF (SP/12/29062).
Greenwood (PI), Plein, Ball, Brown, Sculpher, McCann, Berry. Clinical Evaluation of 3T Magnetic Resonance imaging for the management of patients with Coronary heart disease
The CE-MARC 2 study. £1,177,145.

2012-2014 BHF. Greenwood(PI), Plein, McCann, Conway.
Cardiovascular MR evaluation of the safety and efficacy of Transcatheter Aortic Valve Implantation (TAVI) compared to surgical Aortic Valve Replacement (SAVR).

2013 – 2015 NIHR Doctoral Research Fellowship David Broadbent.
Quantitative cardiac magnetic resonance for the evaluation of sub-clinical fibrosis and microvascular dysfunction in diabetic cardiomyopathy.

2012 – 2015 British Heart Foundation New Horizons grant.
Gadolinium labelled aptamers as targeted contrast agents for use in cardiac MRI-targeting Tenascin-C at sites of cardiac injury and remodelling.

2011 – 2016 British Heart Foundation Senior Clinical Research Fellowship
(Plein) £977k.

2010 – 2012 The Leeds Teaching Hospitals Charitable Foundation.
Myocardial Perfusion Imaging at 3 Tesla.

2009  University of Leeds.
Greenwood (PI), Plein, Ball. SRIF 4 investment in new 3T CMR scanner.

2009 BHF Infrastructure grant (3T CMR) (IG/09/003/27646).
Plein, Greenwood, Ball, Buckley, Ridgway, Radjenovic.

2007-2009. Heart Research UK.
S Plein & Greenwood JP (RG2557/08/10). The evolution of microvascular damage following acute myocardial infarction and its clinical implications.
2006 - 2009 BHF Project Grant (PG/06/116).
A Maqbool, SG Ball, D Mary, J Greenwood, R West. The relationship between genetic polymorphism of the alpha2-adrenergic receptors and the central sympathetic nerve activity.

2006-2009. Heart Research UK (RG2532/07/08).
A Crean & Greenwood JP (PI). Prediction of patient benefit from the revascularisation of chronically occluded coronary arteries by advanced cardiovascular MRI techniques.

2005 - 2010 BHF Programme Grant (RG/05/004).
J Greenwood, S Plein, M Sivananthan, A Radjenovic, J Ridgway, J Nixon, J Brown S Ball (PI). Cardiac magnetic resonance imaging in coronary heart disease: from research to clinical practice (CE-MARC).


Key Collaborations

2013 – 2016 EME project grant.
Plein (PI), Greenwood, Buch, Pavitt, Andrews, Buckley, Baxter. CADERA: Cardiac MRI in Rheumatoid arthritis,

2012-2015 MRC. Witte, Kearney, Cleland, Baxter, Gilthorpe, Plein, Greenwood, Pavitt, Barth, Fleming.
The effect of high-dose vitamin D3 supplementation on submaximal exercise capacity and the pathophysiology of chronic heart failure (VINDICATE: VitamIN D treating patIents with Chronic heArT failure).  £671,336.

2012-2014 NIHR (HSDR) (11/2003/58). Reeves, Bucciarelli-Ducci, Pufulete, Baumbach, Rogers, Harris, Wordsworth, Berry, Greenwood.
Benefit to patients and the NHS of cardiovascular magnetic resonance imaging (CMR) after primary percutaneous coronary intervention (PPCI).

2011-2013 NIHR (EME). McCann, Gershlick, Greenwood, Blackman, Curzon, Dalby, Flather.
Complete Versus Lesion-only PRimary PCI pilot Cardiac MRI substudy (CVLPRI-t-CMR).
2011-2014 NIHR (EME). Gershlick, McCann, Abrams, Goodall, Greenwood, Blackman.
Randomized Controlled Trial Comparing Intracoronary Administration of Adenosine or Sodium Nitroprusside to Control for Attenuation of Microvascular Obstruction during Primary Percutaneous Coronary Intervention)

2009 – 2012 Biomedical Research Centre, Guy’s & St Thomas’ NHS Foundation Trust and King’s College London.
MR perfusion imaging to guide management of patients with stable coronary artery disease.

2007 – 2010 MRC Special Project Grant. Crossman, Morton, Flather, Fox, Gunn, Greenwood, Hall.
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study).

Patients & Volunteers

Download our Patient Information document.

There are currently no volunteer places.

Contact Us


For general enquiries, contact

By Post

Cardiac MRI Unit
B Floor, Clarendon Wing
Leeds General Infirmary
Great George St
Leeds, UK, LS1 3EX
United Kingdom